AMPE

Ampio Pharmaceuticals Inc.
AMPE

Overview Fund Activity
Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

29 hedge funds and large institutions have $102K invested in Ampio Pharmaceuticals Inc. in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+3
Holders Change %
+11.54%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
2
Calls
$618K
Puts
–
Net Calls
+$618K
Net Calls Change
-$479K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$40.1K
2
HF
2
HRT Financial
New York
$36K
3
Morgan Stanley
3
Morgan Stanley
New York
$11.3K
4
CFO
4
CVA Family Office
Colorado
$6.46K
5
TRCT
5
Tower Research Capital (TRC)
New York
$4.67K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$8
2
SS
2
Sunbelt Securities
Texas
$422
3
SCA
3
Stonebridge Capital Advisors
Minnesota
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$0
5
CCMW
5
Cypress Capital Management (Wyoming)
Wyoming
$957
Name Market Value Shares Shares
Change 		Shares
Change %
MAWCM
26
Mine & Arao Wealth Creation & Management
California
$7 3 – –
RFG
27
RFP Financial Group
Georgia
$2 1 – –
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$2 1 +1 New
SCA
29
Stonebridge Capital Advisors
Minnesota
– – -4 Closed
Fidelity Investments
30
Fidelity Investments
Massachusetts
– – -2 Closed
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$0 2 +2 New
1
2